The closer we get to 2028, the more likely it is that the U.S. may settle for short-term solutions that do not meaningfully ...
Add Yahoo as a preferred source to see more of our stories on Google. President Donald Trump’s approach to lowering drug prices has leaned heavily on executive orders and voluntary deals with ...
The third round of the Medicare Drug Price Negotiation Program is moving forward with full manufacturer participation. The program, created under the Inflation Reduction Act, allows CMS to directly ...
On May 12, 2025, the Centers for Medicare & Medicaid Services (CMS) issued draft guidance for the third cycle of the IRA’s Medicare Drug Price Negotiation Program (Negotiation Program). This draft ...
This article is the latest in the Health Affairs Forefront featured topic, “Health Policy at a Crossroads,” produced with the support of the Commonwealth Fund and the Robert Wood Johnson Foundation.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results